| Hans-Günter Meyer-Thompson | Buprenorphin
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study.
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study.
Hoffman K, Peyton ML, Sumner M.
J Addict Med. 2017 Mar 28. doi: 10.1097/ADM.0000000000000301.
Abstract